Literature DB >> 1988662

UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.

M Gwilt1, J E Arrowsmith, K J Blackburn, R A Burges, P E Cross, H W Dalrymple, A J Higgins.   

Abstract

UK-68,798 increased the duration and effective refractory period of cardiac action potentials recorded in vitro from canine ventricular muscle and Purkinje fibers in a concentration dependent manner from 5 nM to 1 microM. The resting membrane potential, amplitude and maximum upstroke velocity of action potentials were unaffected by UK-68,798, indicating the selective class III antiarrhythmic properties of this agent. UK-68,798 (5 nM-1 microM) increased the effective refractory period of isolated guinea pig papillary muscles at stimulation frequencies of 1 Hz and 5 Hz without influencing the conduction velocity, further confirming that UK-68,798 is devoid of class I antiarrhythmic activity including block of the sodium channel. Studies using single voltage clamped guinea pig ventricular myocytes indicated that UK-68,798 at concentrations of 50 nM and 2 microM blocks a time-dependent K+ current, with no appreciable effects on the time-independent K+ current or the inward calcium current. UK-68,798 is therefore a highly selective K+ channel blocking agent with class III antiarrhythmic properties, a profile that holds considerable promise for the therapy of life-threatening cardiac arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988662

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

1.  Kinetics of rate-dependent shortening of action potential duration in guinea-pig ventricle; effects of IK1 and IKr blockade.

Authors:  B A Williams; D R Dickenson; G N Beatch
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT interval.

Authors:  Michael J Allen; Stuart D Oliver; Margaret W Newgreen; Donald J Nichols
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

3.  Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models.

Authors:  Herbert M Himmel; Alexandra Bussek; Michael Hoffmann; Rolf Beckmann; Horst Lohmann; Matthias Schmidt; Erich Wettwer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Dofetilide: a review of its use in atrial fibrillation and atrial flutter.

Authors:  K J McClellan; A Markham
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

5.  Actions and mechanisms of action of novel analogues of sotalol on guinea-pig and rabbit ventricular cells.

Authors:  S P Connors; E W Gill; D A Terrar
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

6.  The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data.

Authors:  Karin Tunblad; Lars Lindbom; Lynn McFadyen; E Niclas Jonsson; Scott Marshall; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-11-15       Impact factor: 2.745

7.  Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.

Authors:  H Nakaya; N Tohse; Y Takeda; M Kanno
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia.

Authors:  S M Cobbe; R W Campbell; A J Camm; A W Nathan; E Rowland; P E Bloch-Thomsen; M Møller; L Jordaens
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

Review 9.  A benefit-risk assessment of class III antiarrhythmic agents.

Authors:  Bente Brendorp; Oledyg Pedersen; Christian Torp-Pedersen; Naji Sahebzadah; Lars Køber
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Electrophysiological mechanisms for antiarrhythmic efficacy and positive inotropy of liriodenine, a natural aporphine alkaloid from Fissistigma glaucescens.

Authors:  G J Chang; M H Wu; Y C Wu; M J Su
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.